Drugs / PESAMPATOR
PESAMPATOR
Trials 16
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 114 trials · 1 missed | ||||||
| Phase 1 | NCT05148481 | Nov 2021 → Jan 2022 | — | Biogen | Completed | No outcome recorded |
| Phase 1 | NCT04068532 | Nov 2019 → Nov 2020 | — | Biogen | Completed | No outcome recorded |
| Phase 1 | NCT04079101 | Oct → Dec 2019 | — | Biogen | Completed | No outcome recorded |
| Phase 1 | NCT02341482 | Feb → Mar 2015 | — | Biogen | Completed | No outcome recorded |
| Phase 1 | NCT02332798 | Jan → Apr 2015 | schizophrenia | Biogen | Completed | No outcome recorded |
| Phase 1 | NCT02228395 | Sep → Nov 2014 | — | Biogen | Completed | No outcome recorded |
| Phase 1 | NCT01749098 | Dec 2012 → Feb 2014 | schizophrenia | Biogen | Completed | No outcome recorded |
| Phase 1 | NCT01646840 | Jul → Sep 2012 | — | Biogen | Completed | No outcome recorded |
| Phase 1 | NCT01518920 | Dec 2011 → Feb 2013 | sensorineural hearing loss disorder | Biogen | Completed | Missed primary |
| Phase 1 | NCT01518894 | Nov 2011 → Mar 2012 | schizophrenia | Biogen | Completed | No outcome recorded |
| Phase 1 | NCT01365338 | Jun 2011 → Dec 2012 | — | Biogen | Completed | No outcome recorded |
| Phase 1 | NCT01511510 | Jun → Nov 2011 | schizophrenia | Biogen | Completed | No outcome recorded |
| Phase 1 | NCT01238679 | Nov 2010 → May 2011 | — | Biogen | Terminated | No outcome recorded |
| Phase 1 | NCT01159483 | Jul → Oct 2010 | — | Biogen | Completed | No outcome recorded |
| Phase 22 trials · 1 missed | ||||||
| Phase 2 | NCT03745820 | Nov 2018 → Mar 2022 | schizophrenia | Biogen | Completed | Missed primary |
| Phase 2 | NCT02855411 | Aug → Sep 2016 | schizophrenia | Biogen | Terminated | No outcome recorded Stop: Business |
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT05152485 Comparator | Dec 2021 → Jan 2022 | — | Biogen | Completed | No outcome recorded |
Evidence & citations 6 cited values
Every value below carries the sentence it was read from. 18 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PESAMPATOR | ChEMBL registry synonym — accepted as the source's own label CHEMBL5095022 ↗ |
| Known as | BIIB104 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05148481 ↗ |
| Known as | PF-04958242 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01518920 ↗ |
| Known as | PF-4958242 | ChEMBL registry synonym — accepted as the source's own label CHEMBL5095022 ↗ |
| Modality | Small molecule | — CHEMBL5095022 ↗ |
| Route | Oral | “administered orally” NCT01159483 ↗ |